Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Birkl-Töglhofer Anna Maria |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Birkl-Toeglhofer, AM; Haybaeck, J; Höftberger, R; Rauscher, A; Birkl, C Altered iron content in superficial and deep white matter in Alzheimer's disease
BRAIN PATHOL. Abstracts. 2023; 33(S1):-20th International Congress of Neuropathology; SEP 13-16, 2023; Berlin, GERMANY. [Poster]
Web of Science

 

Alcaniz, J; Dahlmann, M; Conrad, T; Orthmann, A; Haybaeck, J; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Kratzsch, T; Kuhn, SA; Joedicke, A; Iduna, F; Hoffmann, J; Walther, W Molecular analyses of Glioblastoma patient-derived xenograft (PDX) models identify potential targets in treatment resistant tumors
ONCOL RES TREAT. Abstracts 35. Deutscher Krebskongress. 2022; 45(SUPPL 3):47-47.-35. Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung; NOV 13-16, 2022; Berlin, GERMANY. [Poster]
Web of Science

 

Leber, S; Krassnig, S; Birkl-Toeglhofer, A; Golob-Schwarzl, N; Wodlej, C; Flunkert, S; Hutter-Paier, B; Kalev, O; Weis, S; Haybaeck, J Septin2 and 9 Alterations in Human Post mortem Alzheimer’s Disease Brains
Proceedings of The Lancet Summit, 2021. 2021; -The Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases; Dez 14 - 16, 2021; London (virtual). [Poster]

 

Birkl-Toeglhofer, AM; Bengesser, S; Rieger, A; Fellendorf, F; Platzer, M; Queissner, R; Hamm, C; Maget, A; Morkl, S; Wagner-Skacel, J; Schwarzbraun, T; Haybaeck, J; Reininghaus, E GENE EXPRESSION OF EUKARYOTIC INITIATION FACTORS UPON PROBIOTIC ADMINISTRATION IN DEPRESSIVE PATIENTS
EUR NEUROPSYCHOPHARM. 2019; 29: 1232-1232.-26th World Congress of Psychiatric Genetics (WCPG); OCT 11-15, 2018; Glasgow, SCOTLAND. Doi: 10.1016/j.euroneuro.2018.08.304 [Poster]
Web of Science FullText FullText_MUG

 

Leber, S; Johannes Haybaeck, Stefanie Kraßnig, Anna Töglhofer, Nicole Golob-Schwarzl, Christina Wodlej, Ognian Kalev, Serge Weis, Stephan Sygulla, Marlene Leoni, Stefanie Flunkert, Birgit Hutter-Paier Septin2 and 9 as contributors to alzheimer's disease
Proceedings of the 4th Joint Annual Meeting of the Swiss and Austrian Societies of Pathology. 2019; -JOINT ANNUAL MEETING SGPATH-ÖGPATH-SSCYT 2019 ; 07 - 09 November 2019 ; Luzern. [Poster]

 

Leber SL, Krassnig S, Birkl-Toeglhofer AM, Golob-Shwarzl N, Wodlej C, Llenos IC, Dulay J, Kalev O, Sygulla S, Leoni M, Flunkert S, Hutter-Paier B, Smalla KH, Seidenbecher C, Weis S, Haybaeck J Septin2 and 9 in Alzeimer´s disease.
Proceedings of the Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN). 2019; -Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN); SEPT 19–21, 2019 ; Magdeburg, GERMANY. [Oral Communication]

 

Rieger, A; Bengesser, S; Platzer, M; Fellendorf, F; Queissner, R; Birner, A; Dalkner, N; Mendel, L; Seidl, M; Farber, T; Wetzlmair, L; Heigl, M; Birkl-Toeglhofer, AM; Schwarzbraun, T; Reininghaus, E THE EFFECTS OF PROBIOTICS ON GENE EXPRESSION AND COGNITIVE FUNCTION IN DEPRESSIVE PATIENTS
EUR NEUROPSYCHOPHARM. 2019; 29: 1213-1213.-26th World Congress of Psychiatric Genetics (WCPG); OCT 11-15, 2018; Glasgow, SCOTLAND. Doi: 10.1016/j.euroneuro.2018.08.268 [Poster]
Web of Science FullText FullText_MUG

 

Birkl-Toeglhofer, AM; Birkl, C; Llenos, IC; Weis, S; Haybaeck, J Bipolar Disorder: Hepatic Gene Expression Upon Drug Treatment.
Proceedings of the 6th International Student Congress. 2018; -6th International Student Congress; MAY 31-JUN 2, 2018; Graz, AUSTRIA. [Oral Communication]

 

Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
51. Jahrestagung der ÖGGH; Juni 14 - 16, 2018; Salzburg, AUSTRIA. 2018. [Oral Communication]

 

Golob-Schwarzl N,Krassnig S, Birkl -Toeglhofer A.M, Park Y.N, Gogg-Kamerer M, Puchas P, Vierlinger K, Schröder F, Schicho R, Fickert P, Haybaeck J New Liver Biomarker
102. Annual Meeting of the German Society of Pathology. 2018; -102. Annual Meeting of the German Society of Pathology; May, 2018; Berlin. [Poster]

 

Herzl, A; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Golob-Schwarzl, N; Kalev, O; Leoni, M; Sygulla, S; Weis, S; Haybaeck, J; Inhibiting eIF4F-complex formation might be a novel therapeutic target in Alzheimer’s disease
International Student Congress, ISC 2018; MAY 31- JUN 2, 2018; Graz, AUSTRIA. 2018. [Poster]

 

Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fickert, P; Rinner, B; Haybäck, J; Die Rolle des Interleukin-6 Rezeptors im Zuge der Cholangiozellulären Karzinogenese.
Jahrestagung der Deutschen Gesellschaft für Pathologie. 2018; -102. Jahrestagung der DGP; MAI 24-28, 2018; Berlin. [Poster]

 

Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Töglhofer, AM; Krassnig, S; Niedrist, T; Thalhammer, M; Aigelsreiter, A; Rose-John, S; Fikert, P; Rinner, B; Haybäck, J; Classic and Trans Interleukin-6 Signaling Promotes Cholangiocarcinoma
6th International Students Congress. 2018; -6th International Students Congress; MAY 31 - JUNE 2; Graz, AUSTRIA. [Oral Communication]

 

Leber,SL; Krassnig, S; ;Toeglhofer, AM; Llenos, IC; Dulay, J; Kalev,O; Flunkert, S;Hutter-Paier, B; Weis, S; Haybaeck, J . . Post mortem study: Septin 2 and 9 as contributors to glial pathology in Alzheimer’s and Parkinson’s disease
31. Jahrestagung der Österreichischen Alzheimer Gesellschaft . 2018; -31. Jahrestagung der Österreichischen Alzheimer Gesellschaft; OCT 19 -20, 2018; Graz. [Oral Communication]

 

Rieger, A; Bengesser, S; Platzer, M; Fellendorf, F; Queissner, R; Birner, A; Dalkner, N; Mendel, L; Seidl, M; Färber, T; Wetzlmair, L; Heigl, M; Birkl-Töglhofer, A; Schwarzbraun, T; Reininghaus, E The Effects of Probiotics on Gene Expression and Cognitive Function in Depressive Patients
World Congress of Psychiatric Genetics (WCPG); October 11-15, 2018; Glasgow, Scotland. 2018. [Poster]
FullText

 

Schinagl M; Sele M; Wernitznig S; Pritz E; Bock E; Birkl C; Ropele S; Kraßnig S; Birkl-Töglhofer A; Sygulla S; Leoni M; HaybäckJ; Gössler W; Leitinger G Localising Ferritin and Iron in Human Brain Tissue using Immuno-Electron Microscopy
Doctoral Day; NOV 28, 2018; Graz, Austria. 2018. [Poster]

 

Sele, M; Wernitznig, S; Birkl, C; Ropele, S; Kraßnig, S; Birkl-Töglhofer, A; Sygulla, S; Leoni, M; Haybäck, J; Gössler, W; Leitinger, G Electron microscopic techniques to visualize ferritin in the human brain
Abstract book Retain the brain Doctoral Day 2018. 2018; -Doctoral Day 2018; Nov 28, 2018; Graz, Austria. [Poster]

 

Sele, M; Wernitznig, S; Birkl, C; Ropele, S; Kraßnig, S; Birkl-Töglhofer, A; Sygulla, S; Leoni, M; Haybäck, J; Gössler, W; Leitinger, G; Electron microscopic techniques to visualise iron deposits in the human brain
11th FENS Forum of Neroscience; Jul 7-11, 2018; Berlin, Germany. 2018. [Poster]

 

Sele, M; Wernitznig, S; Birkl, C; Ropele, S; Kraßnig, S; Birkl-Töglhofer, A; Sygulla, S; Leoni, M; Haybäck, J; Gössler, W; Leitinger, G; Iron visualisation in the human brain with electron microscopy
19th International Microscopy Congress; SEP 9-14, 2018; Sydney, Ausralia. 2018. [Oral Communication]

 

Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Herzl, A; Kleinegger, F; Birkl-Toeglhofer, AM; Gantenbein, N; Speicher, I; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J; Die Rolle von eukaryotischen Translations-Initiationsfaktoren als potentielles neues therapeutisches Target beim Neuroblastom
Der Pathologe 39: 94-94. 2018; -102. Jahrestagung der Deutschen Gesellschaft für Pathologie; MAY 24-26,2018; Berlin, GERMANY. [Oral Communication]
FullText

 

Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Herzl, A; Singer, G; Toll, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J Eukaryotic Initiation Factor 4A1 as Potential Therapeutic Target in Neuroblastoma
Proceedings of the Doctoral Day. 2018; -Doctoral Day 2018; NOV 28, 2018; Graz, AUSTRIA. [Poster]

 

Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

Birkl, C; Soellradl, M; Toeglhofer, AM; Haybaeck, J; Pirpamer, L; Fazekas, F; Ropele, S; Langkammer, C; Effect of vendor specific formalin composition and concentration on post-mortem MRI of human brain tissue
Proceedings of the ISMRM 25th Annual Meeting & Exhibition. 2017; -ISMRM 25th Annual Meeting & Exhibition; APR 22-27, 2017; Honolulu, HI, USA. [Poster]

 

Birkl-Toeglhofer, AM; Bengesser, S; Birkl, C; Reininghaus, E; Llenos, IC; Weis, S; Haybaeck, J Hepatic gene expression in bipolar disorder upon psychotic drug treatment
Proceedings of the Doctoral Day 2017. 2017; -Doctoral Day 2017; DEZ 13, 2017; Graz, AUSTRIA. [Poster]

 

Golob-Schwarzl N, Krassnig S, Toeglhofer AM, Park YN, Gogg-Kamerer M, Vierlinger K, Schröder F, Rhee H, Schicho R, Fickert P, Haybaeck J New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors
2017. 2017; -European Congress of Pathology; Sep 2.-6., 2017; Amsterdam. [Poster]

 

Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J Eukaryotic initiation factors (eIFs) in colorectal carcinoma
2017. 2017; -European Congress of Pathology; Sep 2.-6., 2017; Amsterdam. [Poster]

 

Golob-Schwarzl, N; Schweiger, C; Koller, C; Kraßnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; M; Uranitsch, S; Lackner, K; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, CH; Schicho, R; Fickert, P; Lax, S; Haybaeck, J. Eukaryotic initiation factors (eIFs), Biomarker in colorectal carcinoma
2017. 2017; -CBmed Biomarker Conference; 13.2.2017; Graz, Austria. [Poster]

 

Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J Interleukin-6 Receptor influences cholangiocarcinoma progression
VIRCHOWS ARCH. 2017; 471: S325-S326.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands. [Poster]
Web of Science

 

Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Rose-John, S; Fickert, P; Haybaeck, J; Die Expression des Interleukin 6 Rezeptors hat Auswirkungen auf das Cholangiozelluläre Karzinom.
101. Jahrestagung der deutschen Gesellschaft für Pathologie . 2017; JUN 22-24; Erlangen, GERMANY. [Poster]

 

Kleinegger, F; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Rinner, B; Thalhammer, M; Aigelsreiter, A; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J; The Role of Interleukin-6 Receptor Signaling in Cholangiocarcinoma
Proceedings of the Doctoral Day. 2017; -Proceedings of the Doctoral Day.; DEC 13, 2017; Graz, Austria. [Poster]

 

Krassnig, S; Leber,S;Toeglhofer, AM; Llenos, IC; Dulay, J; Kalev,O; Flunkert, S;Hutter-Paier, B; Weis, S; Haybaeck, J Septins might be additional contributors to glial pathology in Alzheimer’s disease and other neurodegenerative disorders
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA. [Poster]

 

Krassnig, S; Leber,S;Toeglhofer, AM; Llenos, IC; Dulay, J; Kalev,O; Flunkert, S;Hutter-Paier, B; Weis, S; Haybaeck, J . Septins might contribute to Alzheimer’s and Parkinson’s disease pathology.
Der Pathologe, Ausgabe 5/2017. 2017; -Herbsttagung der ÖGPath/IAP 2017; SEP 14-16, 2017; Velden, AUSTRIA. [Poster]

 

Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46. [Oral Communication]
Web of Science

 

Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Sygulla, S; Leoni, M; Weis, S; Haybaeck, J; Alterations in the expression levels of eukaryotic initiation factors in Alzheimer’s disease
Der Pathologe Ausgabe 5/2017. 2017; -Herbsttagung der ÖGPath/IAP 2017; SEP 14-16, 2017; Velden, AUSTRIA. [Poster]

 

Krassnig, S; Toeglhofer, AM; Golob-Schwarzl, N; Wodlej, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J Eukaryotic initiation factor 4G (eIF4G) is altered in Alzheimer’s disease and might therefore be involved in pathological mechanisms
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases.. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA. [Poster]

 

Krassnig, S; Wohlrab, C; Orthmann, A;Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J . Eukaryotische Initiationsfaktoren stellen ein potenzielles neues therapeutisches Target für die Behandlung von Gliomen dar
101. Jahrestagung der deutschen Gesellschaft für Pathologie ; JUN 22-24; Erlangen, GERMANY. 2017. [Poster]

 

Krassnig, S;Orthmann, A; Wohlrab, C; Golob-Schwarzl, N; Toeglhofer, A; Wodlej, C; Pennauer, M; Raicht, A; Mahdy Ali, M; Von Campe, G; Gogg-Kamerer, M; Leoni, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J Eukaryotic initiation factors might represent a novel marker to monitor the effectiveness of glioma therapy.
Brain Tumor Meeting 2017; May 18-19, 2017; Berlin, GERMANY. 2017. [Poster]

 

Sele, Mariella; Wernitznig, Stefan; Birkl, Christoph; Ropele, Stefan; Kraßnig, Stefanie; Birkl-Töglhofer, Anna Maria; Sygulla, Stephan; Leoni, Marlene; Haybäck, Johannes; Gössler, Walter; Leitinger, Gerd High Resolution Visualisation of Iron Deposits in the Human Brain.
Abstract book DocDay 2017. 2017; -DocDay 2017; Dez 13, 2017; Graz, Austria. [Poster]

 

Toeglhofer AM, Krassnig S, Golob-Schwarzl N, Kalev O, Leoni M, Wodlej C, Weis S, Haybaeck J Alterations in eukaryotic translation initiation might contribute to Parkinson’s disease pathology
Proceedings of the 13th International Conference on Alzheimer's and Parkinson's Diseases. 2017; -13th International Conference on Alzheimer's and Parkinson's Diseases; MAR 29-APR 2; Vienna, AUSTRIA. [Poster]

 

Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219. [Poster]
Web of Science

 

Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J; Eukaryotic initiation factors are altered in Alzheimer’s disease.
Proceedings of the 29th European Congress of Pathology. 2017; -29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, THE NETHERLANDS. [Poster]

 

Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Birkl-Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J Eukaryotic Translation Initiation Factors and Their Potential Role as Targets in Neuroblastoma
Proceedings of the Doctoral Day. 2017; -Doctoral Day; 13.12.2017; Graz, AUSTRIA. [Poster]

 

Toeglhofer, AM; Fuchs, T; Kimiwada, T; Frei, K; Yonekawa, Y; Haybaeck J Computational assessment of hippocampal sclerosis in mesial temporal lobe epilepsy
Proceedings of the 12th European Congress on Epileptology. 2016; -12th European Congress on Epileptology; SEP 11-15, 2016; Prague, CZECH REPUBLIC. [Poster]

 

Toeglhofer, AM; Krassnig, S; Leoni, M; Weis, S; Haybaeck J Neurotrophic signaling in the liver of neuropsychiatric disorders
Proceedings of the Doctoral Day. 2016; -Doctoral Day; DEC 14, 2016; Graz, AUSTRIA. [Poster]

 

Krassnig, S; Toeglhofer, A; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J; The role of eukaryotic initiation factors (eIFs) in transgenic animal models of Alzheimer’s disease: Tau versus Amyloid.
Doctoral Day; Dez 11, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

 

Krassnig, S; Toeglhofer, A; Flunkert, S; Hutter-Paier B; Weis, S; Haybaeck, J; Alzheimer Krankheit und die Rolle von eukaryotischen Initationsfaktoren (eIFs) in transgenen Mausmodellen-Tau versus Amyloid.
28. Jahrestagung der Österreichischen Alzheimer-Gesellschaft (ÖAG); OKT 23-24, 2015; Linz, AUSTRIA. 2015. [Oral Communication]

 

Töglhofer, AM; Hofer, E; Petrovic, KE; Schmidt, R; Schmidt H Heritability of Age Related Cognition.
Proceedings of the 12th International Conference on Alzheimer's & Parkinson's Diseases. 2015; -12th International Conference on Alzheimer's & Parkinson's Diseases; Mär 18-22, 2015; Nice, FRANCE. [Poster]

 

Töglhofer, AM; Hofer, E; Petrovic, KE; Freudenberger, P; Fixa, A; Schmidt, R, Schmidt, H Heritability of Age Related Cognition.
Proceedings of the ESHG Conference 2014; ESHG Conference; MAY 31 - JUN 03, 2014; Milan, ITALY. 2014; -European Human Genetics Conference 2014; Mai 31 - Jun 03, 2014; Milan, ITALY. [Poster]

 

Sen, A; Freudenberger, P; Töglhofer, AM; Schmidt, R; Schmidt, H Higher plasma concentrations of total carotenoids are associated with slower cognitive decline: Results from the Austrian Stroke Prevention Study.
Jahrestagung der Österreichischen Alzheimer-Gesellschaft.; OCT 24-26, 2013; Vienna, AUSTRIA. 2013. [Oral Communication]
FullText

 

SEN, A; Freudenberger, P; Töglhofer, AM; Schmidt, R; Schmidt, H; Association of higher concentrations of plasma carotenoids with better cognitive performance: Results of the Austrian Stroke Prevention Study.
World Congress of Neurology; SEP 21-23, 2013; Vienna, AUSTRIA. 2013. [Oral Communication]
FullText

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum